Literature DB >> 19805686

Novel breast tissue feature strongly associated with risk of breast cancer.

Kevin P McKian1, Carol A Reynolds, Daniel W Visscher, Aziza Nassar, Derek C Radisky, Robert A Vierkant, Amy C Degnim, Judy C Boughey, Karthik Ghosh, Stephanie S Anderson, Douglas Minot, Jill L Caudill, Celine M Vachon, Marlene H Frost, V Shane Pankratz, Lynn C Hartmann.   

Abstract

PURPOSE: Accurate, individualized risk prediction for breast cancer is lacking. Tissue-based features may help to stratify women into different risk levels. Breast lobules are the anatomic sites of origin of breast cancer. As women age, these lobular structures should regress, which results in reduced breast cancer risk. However, this does not occur in all women.
METHODS: We have quantified the extent of lobule regression on a benign breast biopsy in 85 patients who developed breast cancer and 142 age-matched controls from the Mayo Benign Breast Disease Cohort, by determining number of acini per lobule and lobular area. We also calculated Gail model 5-year predicted risks for these women.
RESULTS: There is a step-wise increase in breast cancer risk with increasing numbers of acini per lobule (P = .0004). Adjusting for Gail model score, parity, histology, and family history did not attenuate this association. Lobular area was similarly associated with risk. The Gail model estimates were associated with risk of breast cancer (P = .03). We examined the individual accuracy of these measures using the concordance (c) statistic. The Gail model c statistic was 0.60 (95% CI, 0.50 to 0.70); the acinar count c statistic was 0.65 (95% CI, 0.54 to 0.75). Combining acinar count and lobular area, the c statistic was 0.68 (95% CI, 0.58 to 0.78). Adding the Gail model to these measures did not improve the c statistic.
CONCLUSION: Novel, tissue-based features that reflect the status of a woman's normal breast lobules are associated with breast cancer risk. These features may offer a novel strategy for risk prediction.

Entities:  

Mesh:

Year:  2009        PMID: 19805686      PMCID: PMC2793038          DOI: 10.1200/JCO.2008.21.5079

Source DB:  PubMed          Journal:  J Clin Oncol        ISSN: 0732-183X            Impact factor:   44.544


  25 in total

1.  Lobular involution: the physiological prevention of breast cancer.

Authors:  Donald Earl Henson; Robert E Tarone; Hala Nsouli
Journal:  J Natl Cancer Inst       Date:  2006-11-15       Impact factor: 13.506

2.  Morphometric studies of age related changes in normal human breast and their significance for evolution of mammary cancer.

Authors:  S W Hutson; P N Cowen; C C Bird
Journal:  J Clin Pathol       Date:  1985-03       Impact factor: 3.411

3.  Efficacy of prophylactic mastectomy in women with unilateral breast cancer: a cancer research network project.

Authors:  Lisa J Herrinton; William E Barlow; Onchee Yu; Ann M Geiger; Joann G Elmore; Mary B Barton; Emily L Harris; Sharon Rolnick; Roy Pardee; Gail Husson; Ana Macedo; Suzanne W Fletcher
Journal:  J Clin Oncol       Date:  2005-03-28       Impact factor: 44.544

4.  BRCA1 mutations in women attending clinics that evaluate the risk of breast cancer.

Authors:  F J Couch; M L DeShano; M A Blackwood; K Calzone; J Stopfer; L Campeau; A Ganguly; T Rebbeck; B L Weber
Journal:  N Engl J Med       Date:  1997-05-15       Impact factor: 91.245

5.  Cancer risk prediction models: a workshop on development, evaluation, and application.

Authors:  Andrew N Freedman; Daniela Seminara; Mitchell H Gail; Patricia Hartge; Graham A Colditz; Rachel Ballard-Barbash; Ruth M Pfeiffer
Journal:  J Natl Cancer Inst       Date:  2005-05-18       Impact factor: 13.506

6.  Cigarette smoking and risk of benign proliferative epithelial disorders of the breast in the Women's Health Initiative.

Authors:  Yan Cui; David L Page; Rowan T Chlebowski; Judith Hsia; F Allan Hubbell; Karen C Johnson; Thomas E Rohan
Journal:  Cancer Causes Control       Date:  2007-02-24       Impact factor: 2.506

7.  Benign breast disease and the risk of breast cancer.

Authors:  Lynn C Hartmann; Thomas A Sellers; Marlene H Frost; Wilma L Lingle; Amy C Degnim; Karthik Ghosh; Robert A Vierkant; Shaun D Maloney; V Shane Pankratz; David W Hillman; Vera J Suman; Jo Johnson; Cassann Blake; Thea Tlsty; Celine M Vachon; L Joseph Melton; Daniel W Visscher
Journal:  N Engl J Med       Date:  2005-07-21       Impact factor: 91.245

8.  Assessment of the accuracy of the Gail model in women with atypical hyperplasia.

Authors:  V Shane Pankratz; Lynn C Hartmann; Amy C Degnim; Robert A Vierkant; Karthik Ghosh; Celine M Vachon; Marlene H Frost; Shaun D Maloney; Carol Reynolds; Judy C Boughey
Journal:  J Clin Oncol       Date:  2008-10-14       Impact factor: 44.544

9.  Crude open biopsy rates for benign screen detected lesions no longer reflect breast screening quality--time to change the standard.

Authors:  A J Maxwell; J M Pearson; H M Bishop
Journal:  J Med Screen       Date:  2002       Impact factor: 2.136

10.  Risk factors for breast cancer in women with proliferative breast disease.

Authors:  W D Dupont; D L Page
Journal:  N Engl J Med       Date:  1985-01-17       Impact factor: 91.245

View more
  31 in total

1.  Lobular involution, mammographic density, and breast cancer risk: visualizing the future?

Authors:  Gretchen L Gierach; Louise A Brinton; Mark E Sherman
Journal:  J Natl Cancer Inst       Date:  2010-10-29       Impact factor: 13.506

2.  Histologic findings in normal breast tissues: comparison to reduction mammaplasty and benign breast disease tissues.

Authors:  Amy C Degnim; Daniel W Visscher; Tanya L Hoskin; Marlene H Frost; Robert A Vierkant; Celine M Vachon; V Shane Pankratz; Derek C Radisky; Lynn C Hartmann
Journal:  Breast Cancer Res Treat       Date:  2011-09-01       Impact factor: 4.872

3.  Twenty-five years of breast cancer risk models and their applications.

Authors:  Mitchell H Gail
Journal:  J Natl Cancer Inst       Date:  2015-02-26       Impact factor: 13.506

4.  Standardized measures of lobular involution and subsequent breast cancer risk among women with benign breast disease: a nested case-control study.

Authors:  Jonine D Figueroa; Ruth M Pfeiffer; Louise A Brinton; Maya M Palakal; Amy C Degnim; Derek Radisky; Lynn C Hartmann; Marlene H Frost; Melody L Stallings Mann; Daphne Papathomas; Gretchen L Gierach; Stephen M Hewitt; Maire A Duggan; Daniel Visscher; Mark E Sherman
Journal:  Breast Cancer Res Treat       Date:  2016-08-03       Impact factor: 4.872

5.  Model for individualized prediction of breast cancer risk after a benign breast biopsy.

Authors:  V Shane Pankratz; Amy C Degnim; Ryan D Frank; Marlene H Frost; Daniel W Visscher; Robert A Vierkant; Tina J Hieken; Karthik Ghosh; Yaman Tarabishy; Celine M Vachon; Derek C Radisky; Lynn C Hartmann
Journal:  J Clin Oncol       Date:  2015-01-26       Impact factor: 44.544

6.  Estrogen receptor and progesterone receptor expression in normal terminal duct lobular units surrounding invasive breast cancer.

Authors:  Xiaohong R Yang; Jonine D Figueroa; Stephen M Hewitt; Roni T Falk; Ruth M Pfeiffer; Jolanta Lissowska; Beata Peplonska; Louise A Brinton; Montserrat Garcia-Closas; Mark E Sherman
Journal:  Breast Cancer Res Treat       Date:  2012-12-28       Impact factor: 4.872

7.  Terminal duct lobular unit involution of the normal breast: implications for breast cancer etiology.

Authors:  Jonine D Figueroa; Ruth M Pfeiffer; Deesha A Patel; Laura Linville; Louise A Brinton; Gretchen L Gierach; Xiaohong R Yang; Daphne Papathomas; Daniel Visscher; Carolyn Mies; Amy C Degnim; William F Anderson; Stephen Hewitt; Zeina G Khodr; Susan E Clare; Anna Maria Storniolo; Mark E Sherman
Journal:  J Natl Cancer Inst       Date:  2014-10-01       Impact factor: 13.506

8.  Pseudoangiomatous stromal hyperplasia and breast cancer risk.

Authors:  Amy C Degnim; Marlene H Frost; Derek C Radisky; Stephanie S Anderson; Robert A Vierkant; Judy C Boughey; V Shane Pankratz; Karthik Ghosh; Lynn C Hartmann; Daniel W Visscher
Journal:  Ann Surg Oncol       Date:  2010-06-22       Impact factor: 5.344

9.  Independent association of lobular involution and mammographic breast density with breast cancer risk.

Authors:  Karthik Ghosh; Celine M Vachon; V Shane Pankratz; Robert A Vierkant; Stephanie S Anderson; Kathleen R Brandt; Daniel W Visscher; Carol Reynolds; Marlene H Frost; Lynn C Hartmann
Journal:  J Natl Cancer Inst       Date:  2010-10-29       Impact factor: 13.506

10.  Relation of Serum Estrogen Metabolites with Terminal Duct Lobular Unit Involution Among Women Undergoing Diagnostic Image-Guided Breast Biopsy.

Authors:  Hannah Oh; Zeina G Khodr; Mark E Sherman; Maya Palakal; Ruth M Pfeiffer; Laura Linville; Berta M Geller; Pamela M Vacek; Donald L Weaver; Rachael E Chicoine; Roni T Falk; Hisani N Horne; Daphne Papathomas; Deesha A Patel; Jackie Xiang; Xia Xu; Timothy Veenstra; Stephen M Hewitt; John A Shepherd; Louise A Brinton; Jonine D Figueroa; Gretchen L Gierach
Journal:  Horm Cancer       Date:  2016-05-02       Impact factor: 3.869

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.